Skip to results
Modify your search
NARROW
1-20 of 60
Authors: Jason A. Roberts
Sort by
Journal Article
Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy Open Access
Zenaw T Wolie and others
JAC-Antimicrobial Resistance, Volume 7, Issue 3, June 2025, dlaf074, https://doi.org/10.1093/jacamr/dlaf074
Published: 13 May 2025
Journal Article
Quantifying cost savings from outpatient parenteral antimicrobial therapy programme: a systematic review and meta-analysis Open Access
Solomon Ahmed Mohammed and others
JAC-Antimicrobial Resistance, Volume 7, Issue 2, April 2025, dlaf049, https://doi.org/10.1093/jacamr/dlaf049
Published: 08 April 2025
Journal Article
A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria Open Access
Getnet M Assefa and others
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 2, February 2025, Pages 334–346, https://doi.org/10.1093/jac/dkae451
Published: 17 December 2024
Journal Article
Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administration Open Access
Fionnuala Murray and others
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 2, February 2025, Pages 347–353, https://doi.org/10.1093/jac/dkae397
Published: 13 December 2024
Journal Article
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model Open Access
Iain J Abbott and others
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 2, February 2025, Pages 413–426, https://doi.org/10.1093/jac/dkae424
Published: 29 November 2024
Journal Article
A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks? Open Access
Saiyuri Naicker and others
JAC-Antimicrobial Resistance, Volume 6, Issue 6, December 2024, dlae186, https://doi.org/10.1093/jacamr/dlae186
Published: 28 November 2024
Journal Article
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administration
Get access
Fionnuala Murray and others
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 1, January 2025, Pages 209–215, https://doi.org/10.1093/jac/dkae398
Published: 11 November 2024
Journal Article
Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment? Open Access
Carleigh Duke and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 11, November 2024, Pages 2980–2989, https://doi.org/10.1093/jac/dkae318
Published: 10 September 2024
Journal Article
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review Open Access
Zenaw T Wolie and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2083–2102, https://doi.org/10.1093/jac/dkae177
Published: 06 June 2024
Journal Article
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework Open Access
Saiyuri Naicker and others
JAC-Antimicrobial Resistance, Volume 6, Issue 2, April 2024, dlae056, https://doi.org/10.1093/jacamr/dlae056
Published: 05 April 2024
Journal Article
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review Open Access
Getnet M Assefa and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 5, May 2024, Pages 946–958, https://doi.org/10.1093/jac/dkae058
Published: 09 March 2024
Journal Article
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients Free
Philip R Selby and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 3, March 2024, Pages 567–577, https://doi.org/10.1093/jac/dkae006
Published: 13 January 2024
Journal Article
Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis Free
Perrin Ngougni Pokem and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 2, February 2024, Pages 429–442, https://doi.org/10.1093/jac/dkad398
Published: 28 December 2023
Journal Article
Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria Free
Daniel Fresán and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 12, December 2023, Pages 2810–2815, https://doi.org/10.1093/jac/dkad296
Published: 12 October 2023
Journal Article
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study Open Access
Danny Tsai and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 8, August 2023, Pages 1963–1973, https://doi.org/10.1093/jac/dkad190
Published: 27 June 2023
Journal Article
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance Open Access
Jason A Roberts and others
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad011, https://doi.org/10.1093/jacamr/dlad011
Published: 04 March 2023
Journal Article
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae—authors’ response Free
Chandra Datta Sumi and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 3, March 2023, Pages 854–857, https://doi.org/10.1093/jac/dkad017
Published: 30 January 2023
Journal Article
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model Open Access
Iain J Abbott and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 2, February 2023, Pages 397–410, https://doi.org/10.1093/jac/dkac402
Published: 07 December 2022
Journal Article
Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients Free
Ming G Chai and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 2, February 2023, Pages 354–358, https://doi.org/10.1093/jac/dkac392
Published: 01 December 2022
Journal Article
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates Free
Chandra Datta Sumi and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3026–3034, https://doi.org/10.1093/jac/dkac273
Published: 29 August 2022